95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.55%
Revenue growth above 1.5x AEM's 13.81%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
29.24%
Gross profit growth above 1.5x AEM's 7.44%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
37.10%
EBIT growth above 1.5x AEM's 9.79%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
37.10%
Operating income growth above 1.5x AEM's 9.79%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
26.98%
Positive net income growth while AEM is negative. John Neff might see a big relative performance advantage.
28.00%
Positive EPS growth while AEM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
28.00%
Positive diluted EPS growth while AEM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.12%
Share reduction more than 1.5x AEM's 5.37%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.09%
Diluted share reduction more than 1.5x AEM's 5.33%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
49.79%
OCF growth above 1.5x AEM's 11.14%. David Dodd would confirm a clear edge in underlying cash generation.
10.57%
FCF growth 75-90% of AEM's 12.73%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
24.38%
10Y revenue/share CAGR under 50% of AEM's 74.87%. Michael Burry would suspect a lasting competitive disadvantage.
22.08%
5Y revenue/share CAGR under 50% of AEM's 45.53%. Michael Burry would suspect a significant competitive gap or product weakness.
5.86%
3Y revenue/share CAGR under 50% of AEM's 50.51%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
26.57%
10Y OCF/share CAGR under 50% of AEM's 228.30%. Michael Burry would worry about a persistent underperformance in cash creation.
46.48%
Below 50% of AEM's 183.29%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
32.07%
3Y OCF/share CAGR under 50% of AEM's 116.65%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
55.82%
Below 50% of AEM's 558.99%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-56.49%
Negative 5Y net income/share CAGR while AEM is 2997.19%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
32.42%
3Y net income/share CAGR 50-75% of AEM's 51.48%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
66.72%
10Y equity/share CAGR at 50-75% of AEM's 99.95%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
27.99%
Below 50% of AEM's 90.62%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
25.20%
Below 50% of AEM's 85.96%. Michael Burry suspects a serious short-term disadvantage in building book value.
13.23%
Below 50% of AEM's 80.55%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
101.95%
Below 50% of AEM's 306.38%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
59.08%
3Y dividend/share CAGR at 50-75% of AEM's 99.02%. Martin Whitman might see a weaker short-term approach to distributing cash.
-26.61%
Firm’s AR is declining while AEM shows 15.74%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-24.39%
Inventory is declining while AEM stands at 1.17%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.37%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.38%
Positive BV/share change while AEM is negative. John Neff sees a clear edge over a competitor losing equity.
269.36%
We have some new debt while AEM reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-18.96%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.